Abiopharma

New Form 11-K - REVVITY, INC. Filed: 2025-06-20 AccNo: 0001193125-25-143538 Size: 192 KB

New Form 4 - INTEGRATED BIOPHARMA INC Filed: 2025-06-20 AccNo: 0001345281-25-000008 Size: 5 KB

New Form 4 - INTEGRATED BIOPHARMA INC Filed: 2025-06-20 AccNo: 0001345281-25-000009 Size: 5 KB

New Form 4 - INTEGRATED BIOPHARMA INC Filed: 2025-06-20 AccNo: 0001345281-25-000007 Size: 5 KB

New Form 4 - INTEGRATED BIOPHARMA INC Filed: 2025-06-20 AccNo: 0001345281-25-000006 Size: 5 KB

Penumbra’s Newly Expanded swiftPAC™ Coil Line Poised to Help Physicians Meet Growing Demand for Neurosurgical Conditions

New Form 4 - CORE MOLDING TECHNOLOGIES INC Filed: 2025-06-20 AccNo: 0001026655-25-000061 Size: 7 KB

Halozyme - Halozyme Announces argenx Received European Commission Approval for VYVGART® Subcutaneous Injection withENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule

argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy

New Form SCHEDULE 13G - Inventiva S.A. Filed: 2025-06-20 AccNo: 0001172661-25-002447 Size: 14 KB

Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

SeaStar Medical - SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering